 |
USPTO OBVIOUSNESS DETERMINATION WAS SUPPORTED BY SUBSTANTIAL EVIDENCE*
Netlist, Inc. v. Micron Tech. Inc., 24-1707
|
September 02, 2026 |
IPO Federal Circuit Summaries |
|
SPECIFICATION SUFFICIENTLY IDENTIFIED STRUCTURAL FEATURES OF CRYSTALLINE POLYMORPH GENUS*
Exelixis, Inc. v. MSN Labs. Private Ltd., 2025-1236
|
August 31, 2026 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DID NOT HAVE SUBJECT MATTER JURISDICTION OVER SETTLEMENT DISPUTE*
T-Mobile US, Inc. v. KAIFI LLC, 2025-1006
|
August 28, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT MAY CONSIDER § 101 ELIGIBILITY AFTER DETERMINING IMPROPER VENUE*
AML IP, LLC v. Bath & Body Works Direct, Inc., 2025-1280
|
August 28, 2026 |
IPO Federal Circuit Summaries |
|
INVENTOR GROUPS LACKED STANDING TO CHALLENGE PATENT COVER’S “RIGHT TO EXCLUDE” LANGUAGE* *
US Inventor, Inc. v. Squires, 24-2378
|
August 21, 2026 |
IPO Federal Circuit Summaries |
|
SECTION 287 MARKING REQUIREMENT APPLIES TO SETTLEMENT LICENSES; FAILURE TO PLEAD LICENSEE COMPLIANCE BARS PRE-SUIT DAMAGES*
VDPP, LLC v. Volkswagen Group of America, Inc., 24-2226
|
August 19, 2026 |
IPO Federal Circuit Summaries |
|
REASONABLY PERTINENT ART NOT LIMITED TO PROBLEM EXPRESSLY IDENTIFIED IN PATENT SPECIFICATION* *
The Nielson Co. (US), LLC v. TVision Insights, Inc., 25-1371
|
August 14, 2026 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT DENIES EN BANC REVIEW OF DESIGN PATENT INFRINGEMENT DECISION* *
|
August 11, 2026 |
IPO Federal Circuit Summaries |
|
SECTION 102 CONDITIONS PRIOR ART ENTITLEMENT TO PRIORITY ON COMPLIANCE WITH SECTION 112(E)*
Dental Monitoring SAS v. Align Tech., Inc., 25-1752
|
August 10, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT IMPROPERLY CONSTRUED CLAIM TERMS IN PRELIMINARY INJUNCTION ORDER* *
Socket Solutions, LLC v. Import Gbl., LLC, 25-1121
|
August 04, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ERRONEOUSLY RELIED ON EXPERT TESTIMONY IN ANTICIPATION DETERMINATION* *
Bd. of Regents of the Univ. of Tex. Sys. v. Boston Sci. Corp., 24-2062, 24-2063
|
July 27, 2026 |
IPO Federal Circuit Summaries |
|
FEDERAL CIRCUIT VACATES COPYRIGHT DAMAGES AWARD FOR ERRONEOUS APPLICATION OF “BOOK OF WISDOM” DOCTRINE* *
4DD Holdings, LLC v. United States, 24-1996
|
July 16, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ERRED IN GRANTING PRELIMINARY INJUNCTION WHERE THERE WAS SUBSTANTIAL QUESTION OVER CLAIM CONSTRUCTION* *
Ridge Corp. v. Kirk NationaLease Co., 25-1254
|
July 13, 2026 |
IPO Federal Circuit Summaries |
|
USPTO MAY REVISIT ISSUES NOT NECESSARY TO PRIOR JUDGMENT ON REMAND*
Intell. Pixels Ltd. v. Sony Interactive Ent. LLC, 24-2174
|
July 10, 2026 |
IPO Federal Circuit Summaries |
|
SPECIFICATION DID NOT GIVE SUFFICIENT GUIDANCE TO ENABLE METHOD OF TREATMENT PATENT* *
Wyeth LLC v. AstraZeneca Pharms. LP, 24-2325
|
July 09, 2026 |
IPO Federal Circuit Summaries |
|
DYFAN REQUIRES ADDITIONAL ANALYSIS UNDER SECTION 112(F)* *
TrackTime, LLC v. Amazon.com Servs. LLC, 24-1102
|
July 02, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CORRECTLY CONSTRUED CLAIMS TO INCLUDE BOTH FREE BASE AND SALT FORM OF COMPOUNDS* *
Otsuka Am. Pharma., Inc. v. Hetero Labs Ltd., 25-2016
|
July 01, 2026 |
IPO Federal Circuit Summaries |
|
PATENT LACKED WRITTEN DESCRIPTION DUE TO TYPOGRAPHICAL ERROR IN PROVISIONAL APPLICATION* *
Enanta Pharms., Inc. v. Pfizer Inc., 25-1427
|
June 23, 2026 |
IPO Federal Circuit Summaries |
|
CLASSIFICATION RESULTS WERE NOT DETERMINATIVE OF DISCOVERABILITY UNDER 35 U.S.C. § 315(E)(2)* *
Ironburg Inventions Ltd v. Valve Corp., 24-2088
|
June 18, 2026 |
IPO Federal Circuit Summaries |
|
IPR CHALLENGE BASED ON VIOLATION OF A SOTERA STIPULATION WAS BARRED UNDER SECTION 314(D)* *
Hafeman v. Google LLC, 24-1600, 24-1601, 24-1602, 24-1603, 24-1604, 24-1605
|
June 05, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ERRED IN OMITTING ABSTRACT IDEA FROM JURY INSTRUCTIONS*
Ollnova Techs. Ltd. v. ecobee Techs. ULC, 25-1045, 25-1046
|
June 04, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ERRED IN OMITTING EXPLANATION OF DETERMINATION OF NO EXCEPTIONALITY* *
AGI Suretrack LLC v. Farmers Edge Inc., 24-1730, 24-1830
|
June 02, 2026 |
IPO Federal Circuit Summaries |
|
TRADE SECRET OWNER VIOLATED STATUTE OF LIMITATIONS* *
Insulet Corp. v. EOFlow, Co. Ltd., 25-1807
|
May 28, 2026 |
IPO Federal Circuit Summaries |
|
PLAINTIFF HAS THE RIGHT TO PURSUE UNJUST ENRICHMENT UNDER DTSA AND STATE TRADE SECRETS* *
Law Versata Software, LLC v. Ford Motor Co., 24-1140, 24-1206, 24-1234
|
May 22, 2026 |
IPO Federal Circuit Summaries |
|
LICENSOR’S RETAINED RIGHTS CONFERRED CONSTITUTIONAL STANDING*
A.L.M. Holding Co. v. Zydex Indus. Private Ltd., 25-1317
|
May 19, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT ERRED IN AWARDING FEES AGAINST PATENT OWNER IN INFRINGEMENT CASE* *
mCom IP, LLC v. City Nat’l Bank of Fla., 24-2089
|
May 15, 2026 |
IPO Federal Circuit Summaries |
|
DISTRICT COURT CORRECTLY CONSTRUED PATENT CLAIMS AS MEASURING PH AT THE STANDARD TEMPERATURE* *
Actelion Pharms. Ltd. v. Mylan Pharms. Inc., 24-1641
|
May 13, 2026 |
IPO Federal Circuit Summaries |
|
ITC DID NOT IMPROPERLY CONSTRUE CLAIM LIMITATION DURING INITIAL DETERMINATION* *
Bissell, Inc. v. Int’l Trade Comm’n, 24-1509, 24-1709
|
May 11, 2026 |
IPO Federal Circuit Summaries |
|
USE OF TERM “ABOUT” IN CLAIMED RANGE RENDERED PATENT INDEFINITE* *
Enviro Tech Chemical Servs., Inc. v. Safe Foods Corp., 24-2160
|
May 05, 2026 |
IPO Federal Circuit Summaries |
|
JUDICIAL REVIEW OF IPR REAL PARTY IN INTEREST DETERMINATION BARRED UNDER 35 U.S.C. § 314(D)* *
Fed. Express Corp. v. Qualcomm Incorp., 24-1236
|
April 29, 2026 |
IPO Federal Circuit Summaries |
|
OPTIMIZED DIGITAL COMMUNICATION CONSTELLATIONS WERE NOT PATENT-ELIGIBLE SUBJECT MATTER* *
Constellation Designs, LLC v. LG Elecs. Inc., 24-1822
|
April 28, 2026 |
IPO Federal Circuit Summaries |
|
PRODUCT FEATURES AND PROCEDURES PREVIOUSLY DISCLOSED IN PATENTS WERE INELIGIBLE FOR TRADE SECRET PROTECTION* *
Int’l Med. Devices, Inc. v. Cornell, 25-1580, 25-1605
|
April 17, 2026 |
IPO Federal Circuit Summaries |
|
NON-HUMANIZED ANTIBODIES WERE REPRESENTATIVE OF GENUS OF HUMANIZED ANTIBODIES* *
Teva Pharms. Int’l GmbH v. Eli Lilly & Co., 24-1094
|
April 16, 2026 |
IPO Federal Circuit Summaries |
|
PRE-TRIAL STIPULATION PROPERLY ESTABLISHED U.S. NEXUS UNDER SECTION 271*
VLSI Tech. LLC v. Intel Corp., 24-1772
|
April 14, 2026 |
IPO Federal Circuit Summaries |
|
SOURCE CODE COMMANDS ARE NOT HEARSAY*
Definitive Holdings v. Powerteq, 24-1761
|
April 14, 2026 |
IPO Federal Circuit Summaries |
|
USPTO’s RELIANCE ON PARTIES’ STIPULATION AGREEMENT WAS HARMLESS ERROR *
Fuente Marketing Ltd. v. Vaporous Techs., LLC, 24-1460
|
April 08, 2026 |
IPO Federal Circuit Summaries |
|
APPELLANT FAILED TO SHOW INJURY OF FACT AS TO SUBSTITUTED CLAIMS*
ironSource LTD. v. Digital Turbine, Inc., 24-1831
|
April 07, 2026 |
IPO Federal Circuit Summaries |
|
COINVENTORS MUST BE PROVIDED NOTICE AND OPPORTUNITY FOR HEARING UNDER SECTION 256(B)*
Fortress Iron, LP v. Digger Specialties, Inc., 24, 2313
|
April 02, 2026 |
IPO Federal Circuit Summaries |
|
MANDATORY STAY OF PROCEEDINGS UNDER 28 U.S.C. § 1659(A)(2) MUST BE FILED WITHIN 30 DAYS OF ORIGINALLY FILED COMPLAINT* *
Ascendis Pharma v. Biomarin Pharma. Inc., 26-1026
|
March 26, 2026 |
IPO Federal Circuit Summaries |
|
SECTION 337 DOES NOT REQUIRE AN EXACT ARTICLE TO FULFILL THE DOMESTIC INDUSTRY REQUIREMENT*
Apple Inc. v. Int’l Trade Comm’n, 24-1285
|
March 19, 2026 |
IPO Federal Circuit Summaries |
